Skip to content
Trial Eligibility
Menu

International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder

NCT05590715

This study is recruiting at 5 US sites in 5 states, according to its ClinicalTrials.gov record last updated .

Summary

To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Autism Spectrum Disorder

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
12 to 65 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Stalicla SA
Last updated on ClinicalTrials.gov
April 27, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arizona · 1

  • SARRC · Phoenix, AZ

California · 1

  • California Neuroscience Research · Sherman Oaks, CA

Illinois · 1

  • Rush University Medical Center · Chicago, IL

Missouri · 1

  • University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders · Columbia, MO

Utah · 1

  • Alpine Research Organization · Clinton, UT

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.